Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Procter & Gamble Company (The) (PG) - free report >>
CVS Health Corporation (CVS) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Procter & Gamble Company (The) (PG) - free report >>
CVS Health Corporation (CVS) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for August 29th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 29th:
CVS Health Corporation (CVS - Free Report) : This healthcare company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.
CVS Health Corporation Price and Consensus
CVS Health Corporation price-consensus-chart | CVS Health Corporation Quote
CVS Health’s shares gained 6.7% over the last one month more than S&P 500’s decline of 3.2%. The company possesses a Momentum Score of A.
CVS Health Corporation Price
CVS Health Corporation price | CVS Health Corporation Quote
ACADIA Pharmaceuticals Inc. (ACAD - Free Report) : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
ACADIA Pharmaceuticals Inc. Price and Consensus
ACADIA Pharmaceuticals Inc. price-consensus-chart | ACADIA Pharmaceuticals Inc. Quote
ACADIA Pharmaceuticals’ shares gained 14.7% over the last one month. The company possesses a Momentum Score of B.
ACADIA Pharmaceuticals Inc. Price
ACADIA Pharmaceuticals Inc. price | ACADIA Pharmaceuticals Inc. Quote
GMS Inc. (GMS - Free Report) : This distributor of construction products has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.
GMS Inc. Price and Consensus
GMS Inc. price-consensus-chart | GMS Inc. Quote
GMS’ shares gained 17.1% over the last one month. The company possesses a Momentum Score of A.
GMS Inc. Price
GMS Inc. price | GMS Inc. Quote
The Procter & Gamble Company (PG - Free Report) : This consumer goods company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.7% over the last 60 days.
Procter & Gamble Company (The) Price and Consensus
Procter & Gamble Company (The) price-consensus-chart | Procter & Gamble Company (The) Quote
Procter & Gamble’s shares gained 4.5% over the last one month. The company possesses a Momentum Score of B.
Procter & Gamble Company (The) Price
Procter & Gamble Company (The) price | Procter & Gamble Company (The) Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>